Medical Developments International Limited (ASX:MVP)

Market Cap	44.50M -33.6%
Revenue (ttm)	40.64M +6.8%
Net Income	-436.00K
EPS	-0.00
Shares Out	112.66M
PE Ratio	n/a
Forward PE	593.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	72,241
Open	0.4000
Previous Close	0.3950
Day's Range	0.3900 - 0.4000
52-Week Range	0.3650 - 0.7650
Beta	1.38
Analysts	Strong Buy
Price Target	2.03 (+413.92%)
Earnings Date	May 27, 2026

About ASX:MVP

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow mete...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 68
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: MVP